biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Sell Something! Do Something!

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jul 18, 2023 4:20pm

191 Views

Post# 35546746

RE:RE:RE:Sell Something! Do Something!

dude, the xb platform is worthless....it's junk which is why the company is shutting down and why they really could not get anyone to get onboard to develop it. Chiesi dumped it which clearly shows the lack of utility. If they saw something of any value, they could scopp this company up for next to nothing. the fact that they just dumped the program for nothing tells you all you need to know. game over

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market